Related Experiment Videos
[Natural antibodies against Toxoplasma]
La Nouvelle Presse Medicale
|June 15, 1974
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Evaluation of reticulocyte count on Cell-Dyn 3500 automate: comparison with a flow cytometry technique].
Annales de biologie clinique·1997
[Variability of INR due to thromboplastin. Comparison of two recombinant thromboplastins and one rabbit thromboplastin].
Annales de biologie clinique·1995
[Pulmonary actinomycosis: caused by Actinomyces odontolyticus?].
La Revue de medecine interne·1993
Balneatrix alpica gen. nov., sp. nov., a bacterium associated with pneumonia and meningitis in a spa therapy center.
Research in microbiology·1993
Two cases of Actinomyces pyogenes infection in humans.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1993
In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.
Fetal diagnosis and therapy·1993
[Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody].
La Nouvelle presse medicale·1982
[Plasmapheresis in autoimmune syndromes. Indications. Results].
La Nouvelle presse medicale·1982
[Relation between monoclonal gammopathy and hepatobiliary disease].
La Nouvelle presse medicale·1982
ASO Editorial: Lymph Node Dissection in the Immunotherapy Era: Friend or Foe?
Annals of surgical oncology·2026
[Analysis of clinicopathological and immunological characteristics of patients with acquired immune deficiency syndrome-associated diffuse large B-cell lymphoma complicated by Talaromyces marneffei infection].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes:A Large Cohort Study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026